Clinical Trials Logo

Heart Failure clinical trials

View clinical trials related to Heart Failure.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03194841 Completed - Heart Failure Clinical Trials

Heart Failure Self-care With the Aid of a Smartphone Application

Start date: August 22, 2016
Phase: N/A
Study type: Interventional

The purpose of this study was the development, and testing of a HF application that was used to provide self-care support to HF patients through a smartphone device. The study appraised current available literature on HF to determine best practices for promoting self-care of HF through direct communication with individuals with HF living at home. For the purpose of this study, smart phone communication was utilized. Smart phone applications allow patients to transmit physiological data, such as weight, blood pressure, heart rate, and symptom data to healthcare providers. Using a secure website, a healthcare worker can access the information and contact the patient via the mobile phone when their data is out of normal range. This study was novel in its approach from what is traditionally offered in that it supported patient self-care decisions by promoting symptom monitoring and offered both tactical and situational skills strategies through at the point education.

NCT ID: NCT03177447 Completed - Clinical trials for Heart Failure, Congestive

ENABLE: CHF-PC (Comprehensive Heartcare For Patients and Caregivers)

Start date: July 1, 2013
Phase: N/A
Study type: Interventional

Background: Early palliative care (EPC) is recommended but rarely integrated with advanced heart failure (HF) care. This pilot study engaged patients and family caregivers to study the feasibility and site differences in a two-site EPC trial, ENABLE CHF-PC (Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers). An EPC feasibility study (4/1/14-8/31/15) was conducted for patients with New York Heart Association (NYHA) Functional Class III/IV HF and their caregivers in academic medical centers in the northeast and southeast U.S. The EPC intervention comprised: 1) an in-person palliative care consultation; and 2) telephonic nurse coach sessions and monthly calls. Patient- and caregiver-reported outcomes were collected for quality of life (QOL), symptom, health, anxiety, and depression outcomes at baseline, 12- and 24-weeks. Linear mixed-models were used to assess baseline to week 24 longitudinal changes. The intervention was tailored to rural, older adults (ageā‰„65) with advanced HF in reducing HF morbidity and improving patient and caregiver QOL and quality of care.

NCT ID: NCT03171038 Completed - Clinical trials for Telemonitoring in Coronary Artery Disease

The TElemonitoring in the Management of Heart Failure (TEMA-HF) 1 Long-term Follow-up Study

Start date: April 1, 2008
Phase: N/A
Study type: Interventional

TEMA-HF 1 Long-Term Follow-up study is a follow-up study of TEMA-HF 1. It assessed the long-term impact of a 6-months telemonitoring program in chronic heart failure patients.

NCT ID: NCT03143881 Completed - Heart Failure Clinical Trials

Assessment Of Educational Strategies In Heart Failure Patients Presenting To The Emergency Department For Care

Start date: June 1, 2015
Phase: N/A
Study type: Interventional

This study evaluates the impact of a new education-based intervention on outcomes in un- and under-insured Heart Failure (HF) patients presenting to the Emergency Department (ED) for care. Intervention patients will receive personalized education regarding their condition, pre- and post-testing of their HF knowledge base, and ED standard of care during the enrollment (index) visit. Patients will then be contacted via telephone 30 days post-index visit for re-testing and reinforcement of previously learned material. Patients in the control group will receive ED standard of care.

NCT ID: NCT03127202 Completed - Heart Failure Clinical Trials

Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulation

Start date: November 2012
Phase: N/A
Study type: Interventional

Evaluation of three left ventricular pacing polarities effectiveness to narrow phrenic nerve stimulation.

NCT ID: NCT03126656 Completed - Clinical trials for Chronic Heart Failure

Effects of Testosterone on Myocardial Repolarization

Start date: September 2016
Phase: Phase 4
Study type: Interventional

The main of the study is to evaluate the effect of testosterone on ventricular repolarization in patients with mild heart failure, at risk for sudden cardiac death. The electrocardiographic markers studied are QT variability index, the short term variability index.

NCT ID: NCT03105726 Completed - Heart Failure Clinical Trials

Medical Care Versus Ventricular Assist Device for the Management of End-stage Heart Failure (MEVADE)

Start date: November 2010
Phase: N/A
Study type: Observational

End-stage heart failure (ESHF) represents a major burden in terms of quality of life, mortality and costs. The current practice in France is to treat patients with ESHF by a combination of drugs and lifestyle interventions before proposing heart transplant (HT) if there is no contraindication. In the Heart and Diabetes Center of Bad Oyenhausen (BO) in Germany, patients presenting with ESHF are preferentially managed by ventricular assist device (VAD) therapy. The primary purpose of this study was to compare the outcomes of these two strategies in the management of ESHF and associated consumption of resources.

NCT ID: NCT03095196 Completed - Diabetes Clinical Trials

Multipolar CRT-d and Diabetes

Start date: September 1, 2012
Phase: N/A
Study type: Observational

Background: Type 2 Diabetes Mellitus (T2DM) is a multi factorial disease, affecting clinical outcomes in failing heart (HF) patients treated by Cardiac Resynchronization Therapy with a defibrillator (CRT-d). Methods: One hundred and ninety five T2DM patients will receive a CRT-d treatment. Randomly the study population will receive a CRT-d via multipolar left ventricle (LV) lead pacing (n 99 as Multipolar group), v/s a CRT-d via bipolar LV pacing (n 96, as Bipolar group). These patients will be followed by clinical, and instrumental assessment, and telemetric device control at follow up. Study design will be to evaluate, in failing heart T2DM patients, cardiac deaths, all cause deaths, arrhythmic events, CRT-d responders rate, hospitalizations for HF worsening, phrenic nerve stimulation (PNS), and LV catheter dislodgment events (and re-intervention for LV catheter re-positioning), comparing multipolar CRT-d v/s bipolar CRT-d group of patients at follow up.

NCT ID: NCT03090724 Completed - Hypertension Clinical Trials

Pharmacokinetics of BIA 5-453 and Its Metabolites

Start date: June 13, 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study was to assess the effects of age on the pharmacokinetic (PK) profile of BIA 5-453 and its metabolites.

NCT ID: NCT03090568 Completed - Hypertension Clinical Trials

Bioavailability Study of BIA 5-453

Start date: July 15, 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study was to compare the bioavailability and tolerability of BIA 5-453 under fasted and fed conditions.